Bigfoot Biomedical Company

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.
Technology: P4 Medicine
Industry: AI, United States, mHealth
Headquarters: Milpitas, California, United States
Zip: 101-250
Founded Date: 2014-11-18
Employees Number: 101-250
Funding Status: Late Stage Venture
Acquisitions Number: 15
Investors Number: 204628488
Total Funding: $1M to $10M
Estimated Revenue: $1M to $10M
Last Funding Date: Convertible Note
Last Funding Type: info@bigfootbiomedical.com

Visit Website
https://twitter.com/BigfootBiomed
https://www.crunchbase.com/organization/bigfoot-biomedical--inc-
Register and Claim Ownership